Synthesis of the first component of complement by primary cultures of human tumors of the colon and urogenital tract and comparable normal tissue.
D000236:Adenoma / Q000276:immunology; D002277:Carcinoma / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D002470:Cell Survival; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D003106:Colon; D003110:Colonic Neoplasms / Q000276:immunology*; D003172:Complement C1 / Q000032:analysis / Q000096:biosynthesis*; D003174:Complement C1 Inactivator Proteins; D003165:Complement System Proteins / Q000096:biosynthesis*; D003513:Cycloheximide / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000276:immunology; D004950:Esterases / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D009092:Mucous Membrane / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D003172:Complement C1; D003174:Complement C1 Inactivator Proteins; D003165:Complement System Proteins; D003513:Cycloheximide; D004950:Esterases